Abnormally high levels of SRC-3, in association with increasing PSA levels and enhanced tumor cell proliferation, were identified in PCa, which led to propose SRC-3 as an independent marker of tumor recurrence [58]. This evidence concerns the gene NCOA3 and posterior cortical atrophy.